Joining a clinical trial for cervical cancer opens the door to new treatments that could have life-changing effects.

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate cancer in 2010, and another was approved in 2015 for melanoma. Since then, ...

Cervical cancer is caused by human papillomavirus HPV and has become a major health concern Read this article to know ...

Newsweek spoke to one of the contributing authors of the study, Tyler Kratzer, an associate scientist II in cancer surveillance research, along with multiple medical experts to un ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating advanced cervical cancer by ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

The following is a summary of "Oncological outcomes after vaginal and robotic-assisted radical trachelectomy in patients with cervical cancer - A single-center prospective cohort study," published in ...

Health experts estimate that nearly 14,000 women in the U.S. will be diagnosed with cervical cancer, with more than 4,000 ...

A cervical cancer drug may elevate the risk of developing ocular surface disease, such as conjunctival scarring and infectious keratitis.

A new cervical cancer treatment is showing promise in boosting survival rates and reducing recurrence What this breakthrough means for patients.

Saskatchewan cervical cancer patients now have access to a specialized radiation therapy treatment previously only available ...